Number one blog for finding anything that has to do with the law. Read up on the law and know your rights. Labor Laws, Wage Laws, Contract Laws, and anything else that has to deal with justice and rights.
Monday, January 6, 2014
Emergency Visits Seen Increasing With Health Law
Saturday, January 4, 2014
Consumers Start Using Coverage Under Health Law
Lisa Maria Garza contributed reporting from San Antonio, and Kimiya Shokoohi from Los Angeles.
Friday, December 13, 2013
Saturday, November 30, 2013
Prototype: In the Health Law, an Open Door for Entrepreneurs
haven’t bothered to visit the exchanges. “The negative publicity that’s come out about the site not functioning has kept people from thinking they can go to it and get a result,” Mr. Sloane says.
Sunday, October 27, 2013
Promised Fix for Health Site Could Squeeze Some Users
Robert Pear reported from Washington, and Sharon LaFraniere from New York. Ian Austen contributed reporting from Ottawa, and Reed Abelson from New York.
Monday, October 7, 2013
Your Money: Questions Often Asked About Health Law
Sunday, October 6, 2013
Letters: The Long, Long Wait for Mental Health Care
Letters for Sunday Business may be sent to sunbiz@nytimes.com.
Sunday, September 29, 2013
DealBook: K.K.R. to Buy Panasonic Health Care Unit for $1.67 Billion
Saturday, September 28, 2013
Your Money: A Guide to the New Health Insurance Exchanges
Sunday, September 15, 2013
Administration Rejects Union Pleas on Health Law
Wednesday, September 11, 2013
Frequent Flier: Really Affordable Health Care, and It Came With a Doorman, Too
Q. How often do you travel for business?
A. About two weeks a month, predominantly to China, Latin America, Europe and the Middle East.
Q. What’s your least favorite airport?
A. Actually, I don’t like any of them. But if I have to pick, I guess I like Charles de Gaulle the least. As an airport, it’s completely useless. The architecture is just so ugly it’s almost compelling.
Q. Of all the places you’ve been, what’s the best?
A. It’s impossible to pick one place, since unlike airports, I actually do like a lot of different places. I spent some time in Gloucestershire, England, and it was absolutely spectacular.
Q. What’s your secret airport vice?
A. I eat too much, specifically Nathan’s hot dogs, pretzel-fried things and bacon rolls. I can’t stop myself.
I still like seeing new places and meeting new people, but I sure don’t get excited about flying anymore, and I travel about 150 days out of the year. It’s O.K. once I’m in the plane, but like most other travelers, I’m not that good with long lines at security or delays. I’m a brand manager for the St. Regis, W Hotels and the Luxury Collection. I can do some things through e-mail, conference calls and even videoconferencing. But there is still a lot that requires those face-to-face meetings. I went to London last year and stayed for maybe half a day. I was meeting with some team members and we got more done in an afternoon by actually being together and talking than relying on technology. I travel to Asia quite a bit and some cultural things take some getting used to. If there are 20 people invited to a dinner, a host will often toast all 20 people, with individual shots. I’ve taken to spitting some of the liquor in a water glass, which is a lot harder than you think when you’re surrounded by people you don’t want to offend. I have not recognized a lot of the food I’ve eaten in Asia, but I have to say most of it was really good. One of the worst experiences anyone can have while traveling is getting sick. I know, because during my first trip to Bangkok for the St. Regis brand back in 2010 I did. Apparently, I was bitten by a bug and when I got up in the morning my eye was swollen shut. Actually, I looked as if I went several rounds with Mike Tyson. My eye was huge. I had to go inspect a hotel construction site, so I put on a pair of sunglasses and hoped for the best. The hotel was only half-done, and lit with construction lights, so I looked kind of ridiculous walking around in the dark with these wraparound shades on my face. I did show my colleagues my eye and their reactions were priceless. I thought they were going to pass out. I realized I needed to get to a hospital, but I was a little scared about what kind of medical care I would encounter. The concierge recommended a hospital, so that’s where I went. At the hospital, I was greeted by a doorman. I’m used to this at hotels, but not at hospitals. The doorman blew a whistle, which alerted an English-speaking nurse to escort me to the waiting room. Within a few minutes I met with a doctor who recommended some medicine to reduce the swelling. I was even escorted to the pharmacy. The whole thing cost only $19 at the time. I was shocked. Not only was the cost astonishingly low for a hospital bill, but it also included all the delights of a five-star hotel, which comes with a higher price tag. What was once the most miserable part of my travels surprisingly became one of the most pleasant, swollen eye and all.By Paul James, as told to Joan Raymond. E-mail: joan.raymond@nytimes.com
Thursday, September 5, 2013
You're the Boss Blog: Business Owners Say They Have Yet to Figure Out Health Care
Sunday, September 1, 2013
Monday, August 5, 2013
Advertising: Songs and Sunscreen Spread the Health Insurance Message
Friday, July 5, 2013
Health Law Delay Puts Exchanges in Spotlight
Tuesday, June 25, 2013
DealBook: Tenet to Acquire Vanguard Health Systems for $1.8 Billion
Saturday, June 15, 2013
DealBook: Talk of Takeover Grows at Health Management Hospital Group
David Albers/Naples Daily NewsPhysicians Regional Medical Center in Naples, Fla., part of Health Management Associates, the third-largest for-profit chain.Ever since the chief executive of Health Management Associates, the for-profit hospital system, abruptly announced nearly three weeks ago that he would be leaving to lead a religious mission in South America, speculation has mounted about whether the company could be headed for a takeover.
Its stock has soared 36 percent to a six-year high. Its largest shareholder appears eager to play a bigger role in determining the company’s next steps, even if that means taking on the board. And executives from the most likely potential buyer have — without naming names — indicated they could be in the market.
This week, H.M.A., which is based in Naples, Fla., said its board had hired financial advisers to help it consider strategic alternatives but also made clear it would not discuss its plans in any detail.
Pressure is intensifying on the company and its board, particularly its chairman, William J. Schoen, who is viewed by some analysts as less than enthusiastic about selling.
A former chief executive who has shaped and reshaped the company several times over the decades, Mr. Schoen, 77, has been chairman for 27 years.
“He’s certainly someone who’s played a very strong role in forming the company’s strategy,” said Darren Lehrich, an analyst at Deutsche Bank. “There could be some protecting-the-legacy issues there.”
H.M.A. is the nation’s third-largest for-profit hospital chain, by number of beds, with 71 locations. It has struggled in recent months with falling inpatient admissions to its hospitals.
While other hospitals also reported weaker financials in the first few months of this year, the company’s revenue may have also been hurt by an investigation by CBS’s “60 Minutes” that ran late last year, highlighting concern over whether patients were being unnecessarily admitted. In the report, several former employees said the company coerced doctors to admit patients to its hospitals, regardless of medical need, to increase company profits.
H.M.A. has denied the accusations, saying admissions are based solely on what is best for patient care.
Among the myriad government investigations and civil lawsuits that the company discloses in its regulatory filings, H.M.A. has also indicated that United States attorney’s offices in seven states were investigating its physician referrals, including financial arrangements and the “medical necessity of emergency room tests and patient admissions.”
The inquiry appears to be part of a broader look by federal regulators into whether some of the nation’s hospitals are pressing emergency physicians and others to admit patients who could be treated without having to stay overnight in the hospital.
H.M.A. said it was cooperating with regulators.
Some Wall Street analysts say those various investigations and lawsuits could turn off potential buyers.
“Buying H.M.A. means dealing with its troubled operations plus escalating risks from burgeoning legal issues that could prove prohibitively expensive,” Vicki Bryan, an analyst at the bond research firm Gimme Credit, wrote in a note to clients earlier this month.
Others note that since a wave of acquisitions several years ago by private equity, most of the deal activity among public hospital systems has been for single hospitals or smaller deals.
“There are a lot of smaller, not-for-profit hospitals that are looking for financial partners,” said Dean Diaz, a senior credit officer at the Moody’s Corporation. “There are a lot of potential targets out there that can be done without necessarily looking for a big transformational deal.”
A series of curious moves kindled the recent speculation around the company.
In early May, Glenview Capital Management, the hedge fund founded by Lawrence M. Robbins, signaled in a regulatory filing that it had increased its stake and now held more than 37 million shares, or 14.6 percent of H.M.A.’s outstanding shares. The filing allowed it to make direct recommendations to the board.
The company’s stock hardly budged on the news. But the filing drew a much sharper, defensive response from the board.
More than two weeks later, at a board meeting, the company adopted a so-called poison pill to thwart any hostile takeover by a large investor. The pill goes into effect if any investor tries to buy 15 percent or more of the company.
Within a few days Glenview issued a clarification that said it had no interest in acquiring the company.
Investors were then surprised in late May when the company announced that its chief executive, Gary D. Newsome, 55, would retire at the end of July to take over as president of the Uruguay-Montevideo Mission in South America.
Mr. Newsome, who became chief executive in 2008, earned nearly $22 million in total compensation over the last three years, according to regulatory filings. Mr. Newsome had been a senior executive at Community Health Systems, another for-profit hospital system.
Gary Newsome is leaving as C.E.O. of the hospital chain.This week, Glenview raised the stakes when it asked the board to remove or change the poison pill in a way that would allow investors to acquire a bigger stake without activating it, according to the regulatory filing.
The letter added that Glenview was evaluating whether to formulate a proposal to make changes “to all or a portion” of the company’s board.
That’s an unusually aggressive and public stance for Mr. Robbins, who observers say prefers to exert his influence on companies in a more friendly, behind-the-scenes way.
Mr. Robbins has been eager for hospital stocks for more than a year, talking them up at a New York investor conference a year ago. Glenview owns stakes in several publicly traded for-profit hospital systems.
The list of potential buyers for H.M.A. isn’t long, with many pointing to Community Health as the most likely candidate.
Citing the company’s success in its $6.8 billion takeover of Triad Hospitals in 2007, an executive for Community Health told investors at a conference in late May that it was “open to doing that again.”
But the executive emphasized that any potential deal would have to be done on friendly terms. Community Health learned that lesson the hard way after its unsuccessful unsolicited bid for Tenet Healthcare in 2010 wound up in an ugly mix of lawsuits and accusations of fraud and wrongdoing between the two hospital systems.
Community Health has disclosed it is also under investigation by the Justice Department, which is seeking information “about our relationships with emergency department physicians, including financial arrangements.” Community said it was cooperating with government officials. The company declined to comment further on the investigation and its potential interest in H.M.A.
The question many are asking is whether H.M.A.’s directors, particularly Mr. Schoen, would welcome even a friendly bid.
In its statement on Wednesday, the board said it had engaged Morgan Stanley and Weil, Gotshal & Manges to consider “strategic alternatives and opportunities available to H.M.A.”
While Mr. Schoen has spurned efforts by others to acquire H.M.A. in recent years, he is certainly no stranger to deal-making. The chairman of a small bank in Naples that he had started, Mr. Schoen joined H.M.A.’s board in 1983. Less than two years later, after setting the company on its course of acquiring rural hospitals, he was named co-chief executive.
Later, in 1988, Mr. Schoen took H.M.A. private and then public again in 1991.
But a few years ago, in 2007, when H.M.A. engaged in serious discussions about a potential buyout with a group of private equity firms, Mr. Schoen thwarted their efforts. He engineered a deal in which the company borrowed $3.25 billion, loading the company up with debt, to pay shareholders $2.4 billion in dividends.
Tuesday, June 11, 2013
Economic Scene: Examinations of Health Costs Overlook Mergers
Monday, June 3, 2013
Paying Till It Hurts: Colonoscopies Explain Why U.S. Leads the World in Health Expenditures
Jo Craven McGinty contributed reporting.